PhytoMab Logo (WIPO, 06.04.2021)
WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke PhytoMab wurde als Bildmarke am 06.04.2021 bei der Weltorganisation für geistiges Eigentum angemeldet.
Logodesign (Wiener Klassifikation)
#Blätter, Nadeln, Zweige mit Blättern oder Nadeln #Briefe, die eine besondere Form des Schreibens darstellen #Farben #Stilisierte Blätter #Ein Blatt #Briefe in schweren Buchstaben #Drei vorherrschende Farben
| Markenform | Bildmarke |
| Aktenzeichen | 1597076 |
| Länder | 
|
| Basismarke |
Nr. 4020200182332,
15. Oktober 2020
|
| Anmeldedatum | 06. April 2021 |
| Ablaufdatum | 06. April 2031 |
Markeninhaber
#606-297, 18, Maebongsan-ro,
Mapo-gu
KR
Mapo-gu
KR
Markenvertreter
4F, 53, Gangnam-daero 94-gil,
Gangnam-gu
KR
Waren und Dienstleistungen
05
Drugs for medical, pharmaceutical and veterinary purposes;
recombinant cells for medical, pharmaceutical and veterinary
purposes; cell lines for medical, pharmaceutical and
veterinary purposes; medical, pharmaceutical and veterinary
preparations for the treatment of cells; stem cells for
medical, pharmaceutical and veterinary purposes; biological
preparations for medical, pharmaceutical and veterinary
purposes; proteins for medical, pharmaceutical and
veterinary purposes; vaccines for medical, pharmaceutical
and veterinary purposes; biological vectors for medical,
pharmaceutical and veterinary purposes; antibiotics for
medical, pharmaceutical and veterinary purposes; anti-cancer
preparations for medical, pharmaceutical and veterinary
purposes; nucleic acid sequences for medical, pharmaceutical
and veterinary purposes; biopharmaceuticals for the
treatment of cancer; biopharmaceuticals for the treatment of
auto-immune diseases; biopharmaceuticals for treatment of
hepatitis; preparations of transformation microorganisms for
medical, pharmaceutical and veterinary purposes;
preparations of microorganisms for medical, pharmaceutical
and veterinary purposes used for biomolecule production;
preparations of gene recombination for medical,
pharmaceutical and veterinary purposes used for biomolecule
production
42
Stem cell research services; research and development for
the pharmaceutical industry; drug discovery services using
plant cells; drug discovery services using stem cells;
development services of new pharmaceutical products;
laboratory research services relating to pharmaceuticals;
testing of pharmaceuticals; medical research;
biotechnological research; biological research; chemistry
services; chemical research; synthetic biology services;
stem cells biology services; research and development
services relating to genetic testing; research and
development services relating to medical, pharmacological
and veterinary science; laboratory research in the field of
pharmaceuticals, biology, biochemistry and chemistry;
research and development services in the field of
microorganisms and cells technology; research services in
the field of chemistry, biochemistry, enzymology, biology,
cell biology and biotechnology
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 19. Dezember 2022 | 2023/3 Gaz | KR | RAW: Partial Ceasing Effect |
| 18. November 2022 | 2022/47 Gaz | US | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 27. Dezember 2021 | 2021/52 Gaz | US | Ablehnung |
| 19. November 2021 | 2021/50 Gaz | CN | Ablehnung |
| 09. November 2021 | 2021/45 Gaz | EM | Ablehnung |
| 06. April 2021 | 2021/22 Gaz | KR | Eintragung |
ID: 141597076